Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
Moma Therapeutics Series B round, May 2022
Moma Therapeutics raised a Series B round for 150,000,000 USD in May, 2022.
Overview
Structured Data
Issues
Contributors
Activity
All edits
Edits on 20 Jan, 2023
Semyon Kolychev
edited on 20 Jan, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Funded Company
Moma Therapeutics
0
Funding Round Date
May 10, 2022
0
Funding Round Amount (USD)
150,000,000
0
Funding Type
Series B Round
0
Investment
Third Rock Ventures
0
Section 32 (venture capital firm)
0
Rock Springs Capital
0
Nextech Invest
0
Casdin Capital
0
Cormorant Asset Management
0
Pavilion Capital
0
Alexandria Venture Investments
0
Date Announced
May 10, 2022
0
Edits on 5 Jun, 2022
Semyon Kolychev
edited on 5 Jun, 2022
Edits made to:
Infobox
(
+8
properties)
Infobox
Investment
Third Rock Ventures
Section 32 (venture capital firm)
Rock Springs Capital
Nextech Invest
Casdin Capital
Cormorant Asset Management
Pavilion Capital
Alexandria Venture Investments
Edits on 12 May, 2022
"Created via: Entity Importer"
Golden AI
created this topic on 12 May, 2022
Edits made to:
Infobox
(
+6
properties)
Moma Therapeutics Series B round, May 2022
Infobox
Is a
Funding round
Funding type
Series B Round
Funded company
Moma Therapeutics
Funding round amount (USD)
150,000,000
Announcement URL
https://www.businesswire.com/news/home/20220510005197/en/MOMA-Therapeutics-Announces-150-Million-Series-B-Financing
Funding round date
May 10, 2022
Find more entities like Moma Therapeutics Series B round, May 2022
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE